53 research outputs found
Exercise in type 2 diabetes: to resist or to endure?
There is now evidence that a single bout of endurance (aerobic) or resistance exercise reduces 24 h post-exercise subcutaneous glucose profiles to the same extent in insulin-resistant humans with or without type 2 diabetes. However, it remains to be determined which group would benefit most from specific exercise protocols, particularly with regard to long-term glycaemic control. Acute aerobic exercise first accelerates translocation of myocellular glucose transporters via AMP-activated protein kinase, calcium release and mitogen-activated protein kinase, but also improves insulin-dependent glucose transport/phosphorylation via distal components of insulin signalling (phosphoinositide-dependent kinase 1, TBC1 domain family, members 1 and 4, Rac1, protein kinase C). Post-exercise effects involve peroxisome-proliferator activated receptor-γ coactivator 1α and lead to ATP synthesis, which may be modulated by variants in genes such as NDUFB6. While mechanisms of acute resistance-type exercise are less clear, chronic resistance training activates the mammalian target of rapamycin/serine kinase 6 pathway, ultimately increasing protein synthesis and muscle mass. Over the long term, adherence to rather than differences in metabolic variables between specific modes of regular exercise might ultimately determine their efficacy. Taken together, studies are now needed to address the variability of individual responses to long-term resistance and endurance training in real life
Socio-cultural influences on the behaviour of South Asian women with diabetes in pregnancy: qualitative study using a multi-level theoretical approach
BACKGROUND: Diabetes in pregnancy is common in South Asians, especially those from low-income backgrounds, and leads to short-term morbidity and longer-term metabolic programming in mother and offspring. We sought to understand the multiple influences on behaviour (hence risks to metabolic health) of South Asian mothers and their unborn child, theorise how these influences interact and build over time, and inform the design of culturally congruent, multi-level interventions. METHODS: Our sample for this qualitative study was 45 women of Bangladeshi, Indian, Sri Lankan, or Pakistani origin aged 21-45 years with a history of diabetes in pregnancy, recruited from diabetes and antenatal services in two deprived London boroughs. Overall, 17 women shared their experiences of diabetes, pregnancy, and health services in group discussions and 28 women gave individual narrative interviews, facilitated by multilingual researchers, audiotaped, translated, and transcribed. Data were analysed using the constant comparative method, drawing on sociological and narrative theories. RESULTS: Key storylines (over-arching narratives) recurred across all ethnic groups studied. Short-term storylines depicted the experience of diabetic pregnancy as stressful, difficult to control, and associated with negative symptoms, especially tiredness. Taking exercise and restricting diet often worsened these symptoms and conflicted with advice from relatives and peers. Many women believed that exercise in pregnancy would damage the fetus and drain the mother's strength, and that eating would be strength-giving for mother and fetus. These short-term storylines were nested within medium-term storylines about family life, especially the cultural, practical, and material constraints of the traditional South Asian wife and mother role and past experiences of illness and healthcare, and within longer-term storylines about genetic, cultural, and material heritage - including migration, acculturation, and family memories of food insecurity. While peer advice was familiar, meaningful, and morally resonant, health education advice from clinicians was usually unfamiliar and devoid of cultural meaning. CONCLUSIONS: 'Behaviour change' interventions aimed at preventing and managing diabetes in South Asian women before and during pregnancy are likely to be ineffective if delivered in a socio-cultural vacuum. Individual education should be supplemented with community-level interventions to address the socio-material constraints and cultural frames within which behavioural 'choices' are made
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
More than several hundreds of millions of people will be diabetic and obese over the next decades in front of which the actual therapeutic approaches aim at treating the consequences rather than causes of the impaired metabolism. This strategy is not efficient and new paradigms should be found. The wide analysis of the genome cannot predict or explain more than 10–20% of the disease, whereas changes in feeding and social behavior have certainly a major impact. However, the molecular mechanisms linking environmental factors and genetic susceptibility were so far not envisioned until the recent discovery of a hidden source of genomic diversity, i.e., the metagenome. More than 3 million genes from several hundreds of species constitute our intestinal microbiome. First key experiments have demonstrated that this biome can by itself transfer metabolic disease. The mechanisms are unknown but could be involved in the modulation of energy harvesting capacity by the host as well as the low-grade inflammation and the corresponding immune response on adipose tissue plasticity, hepatic steatosis, insulin resistance and even the secondary cardiovascular events. Secreted bacterial factors reach the circulating blood, and even full bacteria from intestinal microbiota can reach tissues where inflammation is triggered. The last 5 years have demonstrated that intestinal microbiota, at its molecular level, is a causal factor early in the development of the diseases. Nonetheless, much more need to be uncovered in order to identify first, new predictive biomarkers so that preventive strategies based on pre- and probiotics, and second, new therapeutic strategies against the cause rather than the consequence of hyperglycemia and body weight gain
Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid
Perfluorooctanoic acid (PFOA) is known to
cause developmental toxicity and is a suggested endocrine
disrupting compound (EDC). Early life exposure
to EDCs has been implicated in programming of the
developing organism for chronic diseases later in life.
Here we study perinatal metabolic programming by
PFOA using an experimental design relevant for human
exposure. C57BL/6JxFVB hybrid mice were exposed
during gestation and lactation via maternal feed to
seven low doses of PFOA at and below the NOAEL
used for current risk assessment (3–3000 μg/kg body
weight/day). After weaning, offspring were followed
for 23–25 weeks without further exposure. Offspring
showed a dose-dependent decrease in body weight from
postnatal day 4 to adulthood. Growth under high fat
diet in the last 4–6 weeks of follow-up was increased
in male and decreased in female offspring. Both sexes
showed increased liver weights, hepatic foci of cellular
alterations and nuclear dysmorphology. In females, reductions in perigonadal and perirenal fat pad weights,
serum triglycerides and cholesterol were also observed.
Endocrine parameters, such as glucose tolerance, serum
insulin and leptin, were not affected. In conclusion,
our study with perinatal exposure to PFOA in mice
produced metabolic effects in adult offspring. This is
most likely due to disrupted programming of metabolic
homeostasis, but the assayed endpoints did not provide
a mechanistic explanation. The BMDL of the programming
effects in our study is below the current point of
departure used for calculation of the tolerable daily
intake.The authors wish to acknowledge the support of
the biotechnicians from the team of Hans Strootman at the RIVM animal
facilities. Further technical support was provided by Piet Beekhof,
Hennie Hodemaekers, Sandra Imholz (RIVM), Mirjam Koster
(UU), Stefan van Leeuwen (RIKILT), Jacco Koekkoek and Marja
Lamoree (VU). This study was funded by the European Community’s
Seventh Framework Programme [FP7/2007–2013] under grant agreement
OBELIX 227391
The longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI
<p>Abstract</p> <p>Background</p> <p>Variation in the effects of genetic variants on physiological traits over time or with age may alter the trajectories of these traits. However, few studies have investigated this possibility for variants associated with type 2 diabetes or obesity, and these show little consensus. We aimed to characterise the possible longitudinal associations of common diabetes-susceptibility variants in the <it>KCNJ11</it>, <it>PPARG</it>, <it>TCF7L2, IGF2BP2, CDKAL1, SLC30A8 </it>and <it>HHEX </it>gene loci, with fasting glucose level; and of an obesity-associated variant in the <it>FTO </it>gene, with body mass index (BMI).</p> <p>Methods</p> <p>The study analysed data from the Busselton Health Study (<it>n </it>= 4,554). Cross-sectional association analyses included family data and used the total association test. Longitudinal association analyses of unrelated participant data (<it>n </it>= 2,864) used linear mixed-effects models.</p> <p>Results</p> <p>In cross-sectional analyses, we observed associations of the T allele at the <it>IGF2BP2 </it>single nucleotide polymorphism (SNP) rs4402960 with raised fasting glucose (<it>p </it>= 0.045), and the A allele at the <it>FTO </it>SNP rs9939609 with raised BMI (<it>p </it>= 0.003). Longitudinal analyses showed no significant associations between SNPs and changes in fasting glucose or BMI in the same individuals, either over mean follow-up times of 18.7 and 21.8 years respectively, or with age during adulthood.</p> <p>Conclusions</p> <p>There was no indication that the effects of common type 2 diabetes variants on fasting glucose varied with age during adulthood or over time.</p
- …